VANDA PHARMACEUTICALS INC. Debt Securities, Available-for-sale, Realized Gain (Loss)
VANDA PHARMACEUTICALS INC. (VNDA) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-02-12
- VANDA PHARMACEUTICALS INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-12-31 was $0.00.
- VANDA PHARMACEUTICALS INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-09-30 was $0.00.
- VANDA PHARMACEUTICALS INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-06-30 was $0.00.
- VANDA PHARMACEUTICALS INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-03-31 was $0.00.
- VANDA PHARMACEUTICALS INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $0.00.
- VANDA PHARMACEUTICALS INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2024 was $0.00.
- VANDA PHARMACEUTICALS INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2023 was -$655.00K.
- VANDA PHARMACEUTICALS INC. debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 10-K · filed 2026-02-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | $0.00 derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-12 | $0.00 derived: sum of 3 quarters · filed 2026-02-12 | -$655.00K 10-K · filed 2026-02-12 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | -$655.00K 10-Q · filed 2024-11-07 | -$655.00K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$655.00K 10-Q · filed 2024-08-01 | -$655.00K derived: sum of 3 quarters · filed 2025-02-14 | -$655.00K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | -$655.00K 10-Q · filed 2024-05-09 | -$655.00K derived: sum of 2 quarters · filed 2025-02-14 | -$655.00K derived: sum of 3 quarters · filed 2025-02-14 | -$655.00K derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $0.00 derived: sum of 2 quarters · filed 2025-02-14 | $0.00 derived: sum of 3 quarters · filed 2025-02-14 | $0.00 10-K · filed 2025-02-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-08 | $0.00 derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 | $0.00 derived: sum of 2 quarters · filed 2024-02-08 | $0.00 derived: sum of 3 quarters · filed 2024-02-08 | $0.00 derived: sum of 4 quarters · filed 2024-02-08 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $0.00 derived: sum of 2 quarters · filed 2024-02-08 | $0.00 derived: sum of 3 quarters · filed 2024-02-08 | $12.00K 10-K · filed 2024-02-08 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $12.00K 10-Q · filed 2022-11-03 | $12.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $12.00K 10-Q · filed 2022-08-04 | $12.00K derived: sum of 3 quarters · filed 2023-02-09 | $12.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $12.00K 10-Q · filed 2022-05-06 | $12.00K derived: sum of 2 quarters · filed 2023-02-09 | $12.00K derived: sum of 3 quarters · filed 2023-02-09 | $241.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | $229.00K derived: sum of 3 quarters · filed 2023-02-09 | $229.00K 10-K · filed 2023-02-09 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $229.00K derived: sum of 2 quarters · filed 2021-11-04 | $229.00K 10-Q · filed 2021-11-04 | $229.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $229.00K 10-Q · filed 2021-07-29 | $229.00K derived: sum of 3 quarters · filed 2022-02-24 | $229.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |